Disruptive new platforms and creation of new markets are the end goal for many business development efforts. The dd+p group’s unique combination of robust evidence research and analytics team with deep healthcare commercialization and marketing experience provides critical business insights few others can. We validate all assumptions, supporting where possible with either tenable data or, for more poorly understood factors, with risk-adjusted probabilities defined by known facts.
- market characterizations
- product evaluations and forecasts
- financial analyses
- clinical and economic value analyses
- reimbursement analyses
- in- / out-licensing opportunity assessments
- go / no-go decisions
- procedure assessments
- care path assessments
Click here for more information about our analytics services.